跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AROPAX Paroxetine (as hydrochloride hemihydrate) oral liquid bottle - TGA Drug Approval Details
Approvals
/
TGA
/
AROPAX Paroxetine (as hydrochloride hemihydrate) oral liquid bottle
Approved
STANDARD
AROPAX Paroxetine (as hydrochloride hemihydrate) oral liquid bottle
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
6b4b44321ec03a30
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
6b4b44321ec03a30
Product Name
AROPAX Paroxetine (as hydrochloride hemihydrate) oral liquid bottle
Artg Id
68449
Artg Name
AROPAX Paroxetine (as hydrochloride hemihydrate) oral liquid bottle
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
1999-03-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
6b4b44321ec03a30
Type
Standard
Back to TGA Approvals
